51吃瓜网

Event includes bioprinting demos!
Please register at聽

AT THE FOREFRONT OF TISSUE ENGINEERING, bioprinting is a technology where bio-inks and biomaterials, mixed with cells, are 3D printed, often to construct living tissue models. Join MIAM in welcoming 51吃瓜网Professor of Bioengineering Matt Kinsella and University of Montreal Professor of Ophthalmology May Griffith, as they both give a broad view of this emerging field and explain their own work at its cutting edge.

MATT KINSELLA creates materials-based therapies to treat disease tissues, including using tissue engineering and 3D printing of protein gels to create models (or avatars) of tumors from patient samples. These models are potential alternatives to using animal models in biomedical research, and may allow us to develop more precise and personalized treatments. His lab is also designing and building automated robotic bioprinters that work alongside clinicians in the operating room to aid in the repair or reconstruction of organs following surgeries.

MAY GRIFFITH works on biomimetic materials, and in particular biomaterials that mimic collagen, the major structural protein in the human body. Her team developed the world鈥檚 first cell-free biosynthetic corneal implants that promoted endogenous tissue and nerve regeneration in a human clinical trial, showing for the first time that the cornea can regenerate, even in elderly patients. Her lab also focuses on immunomodulatory materials to suppress inflammation, allowing stable integration of biomaterials and cornea regeneration in patients at high risk for rejecting conventional donor cornea transplantation. They continue to explore new biomaterials with immunomodulatory and drug delivery capacity for clinical application.

The event will be moderated by MIAM Co-Director and 51吃瓜网Professor of Chemical Engineering MARTA CERRUTI.